DCF Studio

    CAH · NYQ · Healthcare

    Cardinal Health, Inc.

    Also onShortfallConsensus DriftCrosscheck

    Implied value per share

    USD 173.89

    Market price

    USD 225.38

    Implied upside

    -22.8%

    5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case

    AdjustedReported capital expenditure averages just 0.24% of revenue, which is too low to be the company's real investment - property trusts and similar structures invest through lines that are not reported as capex. Capex has been set to 1.00% of revenue so the forecast is not handed free growth. The accounts do not separate depreciation from amortisation, so the combined charge is used - if a large part of it is amortisation of an acquisition, the reported capex is probably right and this substitution is not. Override it if the reported figure is right.
    AdjustedCapital expenditure runs at 1.0% of revenue against depreciation of 0.3%. A perpetuity has to be a steady state, so the terminal year uses maintenance capex at depreciation and then charges the reinvestment terminal growth requires (g/ROIC of NOPAT). The bridge is shown under Terminal Value.

    Value Per Share

    Perpetuity growth
    USD 173.89-22.8%
    Exit multiple
    USD 221.18-1.9%
    Market price
    USD 225.38

    Same forecast, different terminal treatment. Percentages vs price.

    Forecast Cashflows

    Reporting currency (USD). Outflows negative.

    0bn1bn2bnFY27FY28FY29FY30FY31
    Nominal FCFFDiscounted to todayUSD
    LineFY27FY28FY29FY30FY31CAGR
    RevenueUSD 273.2bnUSD 293.5bnUSD 315.4bnUSD 338.8bnUSD 364.1bn+7.4%
    EBITUSD 2.8bnUSD 3.0bnUSD 3.2bnUSD 3.5bnUSD 3.7bn+7.4%
    NOPATUSD 2.2bnUSD 2.4bnUSD 2.6bnUSD 2.7bnUSD 3.0bn+7.4%
    Add depreciation & amortisationUSD 943.5mUSD 1.0bnUSD 1.1bnUSD 1.2bnUSD 1.3bn+7.4%
    Less capital expenditureUSD -2.7bnUSD -2.9bnUSD -3.2bnUSD -3.4bnUSD -3.6bn+7.4%
    Less increase in working capitalUSD 1.3bnUSD 1.4bnUSD 1.5bnUSD 1.6bnUSD 1.7bn-7.4%
    Free cashflow to firmUSD 1.7bnUSD 1.9bnUSD 2.0bnUSD 2.2bnUSD 2.3bn+7.4%
    Discount factor0.96210.89060.82430.76300.7063-
    Present valueUSD 1.7bnUSD 1.7bnUSD 1.6bnUSD 1.6bnUSD 1.6bn-0.5%
    Present Value Of The ForecastUSD 8.2bn

    Discount Rate

    Source shown per component. All overridable above.

    Risk-free rate5.00%US 10-year Treasury (^TNX)
    Equity risk premium5.50%Market assumption
    Beta0.678Reported 0.519, pulled toward 1.0 (Blume)
    Cost of equity8.73%Risk-free + beta x equity risk premium
    Cost of debt5.00%Floored at the risk-free rate (implied cost of debt was lower)
    Market capitalisationUSD 52.4bn85.5% of capital
    Total debtUSD 8.9bn14.5% of capital, book value as a proxy
    Tax rate21.0%Effective, capped at statutory
    WACC8.03%E/V x Re + D/V x Rd x (1 - t)

    Terminal Value

    Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.

    Perpetuity growth at 2.50%

    Value per shareUSD 173.89

    82% of EV

    Forecast FCFF, final year
    USD 2.3bn
    Capex at depreciation, working capital in reinvestment
    USD 3.0bn
    Less reinvestment at g/ROIC (4.2% of NOPAT)
    USD -122.9m
    Capitalised
    USD 2.8bn
    ROIC (reported)
    60.0%
    Terminal value, undiscounted
    USD 52.4bn
    Terminal value, discounted
    USD 37.0bn
    Enterprise value
    USD 45.2bn
    Less net debt
    USD 4.0bn
    Equity value
    USD 41.2bn

    Exit at 13.7x EBITDA

    Value per shareUSD 221.18

    85% of EV

    Terminal value, undiscounted
    USD 68.2bn
    Terminal value, discounted
    USD 48.2bn
    Enterprise value
    USD 56.4bn
    Less net debt
    USD 4.0bn
    Equity value
    USD 52.4bn

    Spread between methods: 24%.

    Sensitivity

    Value per share (USD) by discount rate and long-run growth.

    Long-run growth
    Discount rate1.50%2.00%2.50%3.00%3.50%
    6.03%228.25253.27285.36327.99387.42
    7.03%182.59198.22217.28241.04271.52
    8.03%150.98161.49173.89188.73206.83
    9.03%127.82135.27143.84153.82165.59
    10.03%110.15115.62121.82128.89137.03

    Outlined: this model. Green text: above today's price of 225.38. Shading: distance from this model's own value.

    Priced In

    What each input would have to be to justify the current price, one at a time.

    InputModelImpliedGap
    Revenue growth, every year7.4%11.6%+4.1pp
    EBIT margin1.0%1.3%+0.3pp
    Discount rate8.0%6.9%-1.1pp
    Download as Excel

    Live formulas, not pasted numbers - edit a driver and the workbook reprices.

    Yahoo Finance and RBA data. General information, not advice. Methodology.